A drug and disease model for lixisenatide, a GLP-1 receptor agonist in type 2 diabetes
Version of Record online: 19 OCT 2013
© 2013, The American College of Clinical Pharmacology
The Journal of Clinical Pharmacology
Volume 54, Issue 3, pages 267–278, March 2014
How to Cite
Wilkins, J. J., Dubar, M., Sébastien, B. and Laveille, C. (2014), A drug and disease model for lixisenatide, a GLP-1 receptor agonist in type 2 diabetes. Journal of Clinical Pharma, 54: 267–278. doi: 10.1002/jcph.192
- Issue online: 11 FEB 2014
- Version of Record online: 19 OCT 2013
- Accepted manuscript online: 3 OCT 2013 10:13AM EST
- Manuscript Accepted: 19 SEP 2013
- Manuscript Received: 12 AUG 2013
Options for accessing this content:
- If you are a society or association member and require assistance with obtaining online access instructions please contact our Journal Customer Services team.
- If your institution does not currently subscribe to this content, please recommend the title to your librarian.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- New Users: Please register, then proceed to purchase the article.
Login via OpenAthens
Search for your institution's name below to login via Shibboleth.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!